| 000 | 03052cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223032659.0 | ||
| 008 | 210125s2020 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.24.03.Ph.D.2020.Ma.P | ||
| 100 | 0 | _aMarwa Atef Abdelkader Khalifa | |
| 245 | 1 | 0 |
_aPulsed dye laser alone versus its combination with topical Ivermectin 1% in treatment of rosacea : _bRandomized comparative study / _cMarwa Atef Abdelkader Khalifa ; Supervised Hisham Ali Shokeir , Arwa Mohammad Hassan , Mai Abdelraouf Osman |
| 246 | 1 | 5 | _aدراسة مقارنة عشوائية بين ليزر الصبغة النبضى و ليزر الصبغة النبضى مع اضافة الايفرميكتين الموضعى 1% فى علاج الوردية |
| 260 |
_aCairo : _bMarwa Atef Abdelkader Khalifa , _c2020 |
||
| 300 |
_a167 P . : _bcharts ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - National Institute of Laser - Department of Laser Application in Medical and Biological | ||
| 520 | _aBackground: Rosacea is a chronic disorder characterized by a variety of clinical manifestations. Four subtypes exist. Rosacea is commonly observed in individuals with Fitzpatrick skin types 1 and 2; Females over the age of 30 are most commonly affected. Ivermectin 1% cream is a topical anti-parasitic agent which has a therapeutic effect due to its activity against demodex mites. PDL have become a mainstay for treating PWS, facial telangiectasias, and rosacea due to their safety and efficacy. Aim of the study: the aim of this study was to provide a comprehensive clinical and dermatoscopic comparative study between the efficacy and safety of pulsed dye laser alone versus its combination with topical ivermectin 1% in the treatment of rosacea.Patients and methods: According to treatment protocol the patients were scheduled to undergo 4 laser sessions with 4 week intervals. Regarding PDL treatment, the laser parameters applied in this study were (5to7 mm spot size, a duration of 450 microsecond and a wavelength of 585 nm, 5 to 6.5 j/cm2). Results: The present study demonstrated the clinical and dermatoscopic effectiveness of both PDL and combined PDL and ivermectin 1% cream for the treatment of rosacea. Both groups showed high score of improvement. Moreover the combined PDL and ivermectin 1% cream was found to have a greater treatment effect than PDL alone, according to the improvement score, and satisfaction score. However, this difference wasn't significant (p= 0.296), (p=0.341) in papular and erythema type respectively | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aPDL | |
| 653 | 4 | _aRosacea | |
| 653 | 4 | _aTopical Ivermectin 1% | |
| 700 | 0 |
_aArwa Mohammad Hassan , _eSupervisor |
|
| 700 | 0 |
_aHisham Ali Shokeir , _eSupervisor |
|
| 700 | 0 |
_aMai Abdelraouf Osman , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aAmira _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c79716 _d79716 |
||